Study on the Prevalence of Depression and Anxiety among Diabetes Mellitus patients in Tertiary Care Hospital- A Prospective Cross-sectional Study.


  • Pem Tamang Department of Pharmacy Practice. Sri Venkateshwara College of Pharmacy, RVS Nagar, Chittoor- 517127, Andra Pradesh, INDIA.



Diabetes, Anxiety, Depression, risk factors, Hospital Anxiety and Depression Scale, Hypothalamus Pituitary Adrenal axis, Sympathetic Nervous System.


Background: Diabetes mellitus is one of the most predominant, chronic disease afflicting globally with its amplifying burden. The association of diabetes with psychological disorders exists with depression and anxiety being the most common, often remains undiagnosed or unidentified eventually leading to a decline in functional abilities and self-care, worsening the health profile of the patients and contributing to both morbidity and mortality. This study explores the association of psychiatric problems with diabetes mellitus and their related risk factors. Objectives: To investigate the association and the prevalence of psychiatric disorders (depression and anxiety) among diabetic patients and access their associated risk factors. Methods: A prospective cross-sectional study was conducted for six months in 105 diabetic patients from the outpatient department. Hospital Anxiety and Depression Scale (HADS) was used to evaluate the symptoms of anxiety and depression. Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 25.0. Results: Overall 53(50.5%) were observed with the symptoms of anxiety while 45(42.9%) with symptoms of depression respectively. The prevalence of marked anxiety and depression was observed higher in a female. Anxiety and depression were also common among participants with moderate social support. Anxiety and depression were greater among patient who were illiterate (OR=1.50, 95% CI 0.92-5.38), unemployed (OR=7.50, 95% CI 1.29-43.61) with low income (PR=3.09 95% CI 0.92-10.36) and who were retired (OR=6.00, 95% CI 0.81-44.35).Conclusion: The result showed a high prevalence of depression and anxiety among female than in the male. Most of the patients developed moderate or severe anxiety and depression. Various factors such as low income, age, low education, unemployed, uncontrolled diabetes were associated with anxiety and depression. Awareness programs and health education should be conducted. Counseling and appropriate medication should be initiated to reduce future complications.


Key words: 


Download data is not yet available.

Author Biography

Pem Tamang, Department of Pharmacy Practice. Sri Venkateshwara College of Pharmacy, RVS Nagar, Chittoor- 517127, Andra Pradesh, INDIA.

Department of Pharmacy Practice. Sri Venkateshwara College of Pharmacy, RVS Nagar, Chittoor- 517127, Andra Pradesh, INDIA.


1. India State-Level Disease Burden Initiative Diabetes Collaborators. The increasing burden of diabetes and variations among the states of India: The Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018; 6(12):e352–62. Cited in PubMed; PMID 30219315.
2. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E. et al. Diabetes mellitus, fasting blood glucose concentration and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet.2010 ;375(9733):2215-22.
3. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge. et al. IDF Diabetes Atlas: Global estimate of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018 ;138:271-81.
4. World Health Organization. Geneva: Global report on diabetes. c2016.
5. Gemeay EM, Moawed SA, Mansour EA, Ebrahiem NE, Moussa IM, Nadrah WO. The association diabetes and depression. Saudi Med Journal. 2015; 36(10):1210-1215.
6. EI Mahalli AA. Prevalence and predictiors of depression among type 2 diabetes mellitus outpatients in Estern Province, Saudi Arabia. Int J Health Sci (Qassim) 2015 Apr; 9(2).
7. Al-Shehri SZ, Sabra AA, Taha AZ, Khamis AH, Hafez AS. Depression and Anxiety among Males Attending Primary Health Care Centers, Eastern Saudi Arabia: Prevalence and Predictors. Life science journal. 2012; 9(3):128-133.
8. Chen S, Zhang Q, Dai G, Hu J, Zhu C, Su L. et al. Association of depression with pre-diabetes, undiagnosed diabetes and previously diagnosed diabetes: a meta-analysis. Endocrine. 2016 ;53(1):35-46.
9. Grover S, Dutt A, Avasthi A. An overview of Indian research in depression. Indian Journal of Psychiatry. 2010; 52(7):178-88.
10. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 201 2;142:8-21.
11. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res.2002; 53:1053-60.
12. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med.2009; 26:153–61
13. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol.2009; 5:374-381.
14. Kyrou I,Tsigos C. Stress hormones:physiological stress and regulation of metabolism. CurrOpinPharmacol. 2009; 9:787-793.
15. Wang X, Bao W, Liu J, Ouyang YY,Wang D, Rong S. et al. Inflammatory markers and risk of type 2 diabetes: asystematic review and meta-analysis. Diabetes Care. 2013;36:166-175.
16. Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A. Type 1 diabetes
mellitus and major depressive disorder: Evidence for a biological link.Diabetologia. 2011; 54(10):2483-2493.
17. Karam EG, Mneimneh ZN, Fayyad JA, Dimassi H, karam AN, Nasser SC. Lifetime prevalence of mental health diorders: First onsent, treatment and exposure to war- the Lebanon study. PLOS Med. 2008; 5(4):61.
18. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP. et al.Prevalence, severity and unmet need for treatment of mental disorders in the World Health Organization World Metal Health Surveys. JAMA. 2004 Jun2; 91(21):2581–90.
19. Mikaliukestiene A, Zagminas K, Juozulynas A, Narkauskaite L, Salyga J, Jankauskiene K. et al. Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monit. 2014; 20:182-190.
20. Tellez-Zenteno JF, Cardiel MH: Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res, 2002; 33:53-60
21. Engum A, Mykeltun A, Midthjell K et al: Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care, 2005; 28:1904-09
22. Karlson B, Agardh CD: Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients. Diabet Med, 1997; 14:1066-72.
23. Pouwer F. Should we screen for emotional distress in type 2 diabetes mellitus?Nat16 Rev Endocrinol 2009; 5:665–71
24. Papelbaum M, Moreira RO, Coutinho W, Kupfer R, Zagury L, Freitas S, et al. Depression, glycemic control and type 2 diabetes. DiabetolMetabSyndr 2011; 3:26.
25. Joseph N, Unnikrishnan B, Raghavendra Babu YP, Kotian MS, Nelliyanil M. Proportion of depression and its determinants among type 2 diabetes mellitus patients in various tertiary care hospitals in Mangalore city of South India. Indian J Endocrinol Metab 2013; 17:681–8.



How to Cite

Tamang, P. (2020). Study on the Prevalence of Depression and Anxiety among Diabetes Mellitus patients in Tertiary Care Hospital- A Prospective Cross-sectional Study. Asian Journal of Pharmaceutical Research and Development, 8(2), 26–32.